Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+CD25+ regulatory T cells

Cell Death and Differentiation

Volumn 14, Issue 12, 2007, Pages 2076-2084

  Ren, X ^a   Ye, F ^a   Jiang, Z ^a   Chu, Y ^a   Xiong, S ^a   Wang, Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DEATH RECEPTOR 5; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALLOGRAFT; ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; GRAFT SURVIVAL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN GRAFT; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD95; CELL DEATH; CELL PROLIFERATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; T-LYMPHOCYTES, REGULATORY;

EID: 36248995916     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402220     Document Type: Article

References (35)

1. Schwartz RH. Natural regulatory T cells and self-tolerance. Nat Immunol 2005; 6: 327-330.
2. Sakaguchi S, Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 2005; 24 211-226.
3. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immumol 2006; 6: 295-307.
4. La Cava A, Van, Kaer L, Fu Dong S. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 2006; 27: 322-327.
5. Thomton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296.
6. Piccirillo CA, Shevach EM. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001; 167: 1137-1140.
7. Shevach EM, McHugh RS, Piceirillo CA, Thomton AM. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001; 182: 58-67.
8. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 2004; 172: 834-842.
9. Piccirillo CA, Letterio JJ, Thomton AM, McHugh RS, Mamura M, Mozuhara H et al. CD4(+)CD25(+) regulatory T cells can mediate sopressor function in the absence of transtorming growth factor beta1 production and responsiveness. J Exp. Med 2002; 196: 237-246.
10. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S, Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3: 134-142.
11. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M et al. CD4(+)CD25(+) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311-328.
12. Taylor PA, Less CJ, Fournier S, Allison JP, Sharpe AH, Blazer BR. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]. J Immunol 2004; 172: 34-39.
13. Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004; 101: 10398-10403.
14. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LWJ, Kullberg B et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116: 485-494.
15. Liu H, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006; 103: 7048-7053.
16. Pang G, Guo Z, Kiniwa Y, Pang W, Fu T, Wang DY et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005; 309: 1380-1384.
17. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21: 589-601.
18. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174: 1783-1786.
19. Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytomotric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 2001; 253: 177-187.
20. Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRIo thymocytes in vivo. Science 1990; 250: 1720-1723.
21. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
22. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323-370.
23. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H et al. Regulatory T cells suppress tumor-specific CD8T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005; 102: 419-424.
24. Nelson D, Bundell C, Robinson B. in vivo cross-presentation of a soluble protein antigen: Kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol 2000; 165: 6123-6132.
25. Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H. Nature's TRAIL - on a path to cancer immunotherapy. Immunity 2003; 18: 1-6.
26. Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: Role of apoptosis in T helper subset differentiation. Cell Death Differ 2003; 10: 203-210.
27. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chan YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 2003; 4: 255-260.
28. Miyara M, Sakaguchi S. Narural regulatory T cells: Mechanism of suppression. Trends Mol Med 2007; 13: 108-116.
29. Thomton AM, Piccirillo CA, Shevach EM. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 2004; 34: 366-376.
30. Shevach EM, Stephens GL. The GITR-GITRL interaction: Co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006; 6: 613-618.
31. Zhao DM, Thornton AM, DiPaolo RJ, Shavach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006; 107: 3925-3932.
32. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004
33. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
34. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006; 311: 1160-1164.
35. Tomita Y. Yoshikawa M, Zhang QW, Shimizu I, Okano S, Iwai T et al. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide. J Immunol 2000; 165: 34-41.